TGF-β/Smad3 signaling pathway is activated in synovium of patients with rheumatoid arthritis, being involved with Smad7 deficiency, and enhancement of Th17 and Th1 immune response [32]. Here, SMAD7 is linked to rheumatoid arthritis.